{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:23:51Z","timestamp":1789759431122,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30EY029136"],"award-info":[{"award-number":["F30EY029136"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32EY024236"],"award-info":[{"award-number":["T32EY024236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM007250"],"award-info":[{"award-number":["T32GM007250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jdcr.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T19:39:30Z","timestamp":1619293170000},"page":"85-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The role of platelet-rich plasma therapy in refractory folliculitis decalvans"],"prefix":"10.1016","volume":"12","author":[{"given":"Susie","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Atanaskova Mesinkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2021.04.008_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8019.2008.00204.x","article-title":"Folliculitis decalvans","volume":"21","author":"Otberg","year":"2008","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jdcr.2021.04.008_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2018.07.050","article-title":"Updates in therapeutics for folliculitis decalvans: a systematic review with evidence-based analysis","volume":"80","author":"Rambhia","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2021.04.008_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/DSS.0000000000001635","article-title":"Use of platelet-rich plasma in cicatricial alopecia","volume":"45","author":"Dina","year":"2019","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jdcr.2021.04.008_bib4","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.jaad.2018.05.029","article-title":"Platelet-rich plasma for the treatment of lichen planopilaris","volume":"79","author":"Jha","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.04.008_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaad.2020.07.006","article-title":"Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial","volume":"83","author":"Shapiro","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.04.008_bib6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jaad.2020.06.1021","article-title":"The effect of platelet-rich plasma on female androgenetic alopecia: a randomized controlled trial","volume":"83","author":"Dubin","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2021.04.008_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yexcr.2017.02.012","article-title":"Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage","volume":"352","author":"Moussa","year":"2017","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.jdcr.2021.04.008_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1128\/AAC.43.5.1111","article-title":"In\u00a0vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action","volume":"43","author":"Xiong","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jdcr.2021.04.008_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/516120","article-title":"The role of platelets in antimicrobial host defense","volume":"25","author":"Yeaman","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jdcr.2021.04.008_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2180-13-47","article-title":"Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity","volume":"13","author":"Drago","year":"2013","journal-title":"BMC Microbiol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:23:17Z","timestamp":1762474997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":10,"alternative-id":["S2352512621002708"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.04.008","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of platelet-rich plasma therapy in refractory folliculitis decalvans","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}